Found: 281
Select item for more details and to access through your institution.
Selection of Second-line Anti-angiogenic Agents After Failure of Bevacizumab-containing First-line Chemotherapy in Metastatic Colorectal Cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Phase I dose-escalation study of the safety, tolerability, and pharmacokinetics of aflibercept in combination with S-1 in Japanese patients with advanced solid malignancies.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 5, p. 1390, doi. 10.1007/s10637-019-00888-z
- By:
- Publication type:
- Article
Retrospective comparison of nab-paclitaxel plus ramucirumab and paclitaxel plus ramucirumab as second-line treatment for advanced gastric cancer focusing on peritoneal metastasis.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 2, p. 533, doi. 10.1007/s10637-019-00822-3
- By:
- Publication type:
- Article
Phase I study of the anti-heparin-binding epidermal growth factor-like growth factor antibody U3-1565 with cetuximab in patients with cetuximab- or panitumumab-resistant metastatic colorectal cancer.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 2, p. 410, doi. 10.1007/s10637-019-00782-8
- By:
- Publication type:
- Article
Clinical outcomes of patients with G1/G2 neuroendocrine tumors arising from foregut or hindgut treated with somatostatin analogs: a retrospective study.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 3, p. 573, doi. 10.1007/s10637-018-0669-7
- By:
- Publication type:
- Article
Phase I study of TAS-102 and irinotecan combination therapy in Japanese patients with advanced colorectal cancer.
- Published in:
- Investigational New Drugs, 2015, v. 33, n. 5, p. 1068, doi. 10.1007/s10637-015-0271-1
- By:
- Publication type:
- Article
A phase II trial of a selective c-Met inhibitor tivantinib (ARQ 197) monotherapy as a second- or third-line therapy in the patients with metastatic gastric cancer.
- Published in:
- Investigational New Drugs, 2014, v. 32, n. 2, p. 355, doi. 10.1007/s10637-013-0057-2
- By:
- Publication type:
- Article
Phase I study of sunitinib plus S-1 and cisplatin in Japanese patients with advanced or metastatic gastric cancer.
- Published in:
- Investigational New Drugs, 2014, v. 32, n. 2, p. 261, doi. 10.1007/s10637-013-9948-5
- By:
- Publication type:
- Article
A phase I study of intravenous aflibercept with FOLFIRI in Japanese patients with previously treated metastatic colorectal cancer.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 4, p. 910, doi. 10.1007/s10637-012-9895-6
- By:
- Publication type:
- Article
First report of the safety, tolerability, and pharmacokinetics of the Src kinase inhibitor saracatinib (AZD0530) in Japanese patients with advanced solid tumours.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 1, p. 108, doi. 10.1007/s10637-012-9809-7
- By:
- Publication type:
- Article
Phase I and pharmacokinetic study of dacomitinib (PF-00299804), an oral irreversible, small molecule inhibitor of human epidermal growth factor receptor-1, -2, and -4 tyrosine kinases, in Japanese patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2012, v. 30, n. 6, p. 2352, doi. 10.1007/s10637-011-9789-z
- By:
- Publication type:
- Article
Phase I results from a two-part Phase I/II study of cediranib in combination with mFOLFOX6 in Japanese patients with metastatic colorectal cancer.
- Published in:
- Investigational New Drugs, 2012, v. 30, n. 4, p. 1511, doi. 10.1007/s10637-011-9693-6
- By:
- Publication type:
- Article
Phase II study of sunitinib as second-line treatment for advanced gastric cancer.
- Published in:
- Investigational New Drugs, 2011, v. 29, n. 6, p. 1449, doi. 10.1007/s10637-010-9438-y
- By:
- Publication type:
- Article
Prospective Evaluation of the Optimal Duration of Bed Rest After Vascular Interventions Using a 3-French Introducer Sheath.
- Published in:
- CardioVascular & Interventional Radiology, 2015, v. 38, n. 1, p. 40, doi. 10.1007/s00270-014-0892-3
- By:
- Publication type:
- Article
Targeting myeloid villains in the treatment with immune checkpoint inhibitors in gastrointestinal cancer.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.1009701
- By:
- Publication type:
- Article
S-1 and Oxaliplatin Versus Tegafur-uracil and Leucovorin as Postoperative Adjuvant Chemotherapy in Patients With High-risk Stage III Colon Cancer (ACTS-CC 02): A Randomized, Open-label, Multicenter, Phase III Superiority Trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
A Phase II Study of Regorafenib With a Lower Starting Dose in Patients With Metastatic Colorectal Cancer: Exposure-Toxicity Analysis of Unbound Regorafenib and Its Active Metabolites (RESET Trial).
- Published in:
- 2020
- By:
- Publication type:
- journal article
Planned Safety Analysis of the ACTS-CC 02 Trial: A Randomized Phase III Trial of S-1 With Oxaliplatin Versus Tegafur and Uracil With Leucovorin as Adjuvant Chemotherapy for High-Risk Stage III Colon Cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Erratum.
- Published in:
- Clinical Colorectal Cancer, 2011, v. 10, n. 1, p. 7, doi. 10.3816/CCC.2011.n.001
- By:
- Publication type:
- Article
Hepatic Arterial Infusion of 5-Fluorouracil for Patients With Liver Metastases From Colorectal Cancer Refractory to Standard Systemic Chemotherapy: A Multicenter, Retrospective Analysis.
- Published in:
- Clinical Colorectal Cancer, 2010, v. 9, n. 5, p. 305, doi. 10.3816/CCC.2010.n.044
- By:
- Publication type:
- Article
Randomised phase II trial of trifluridine/tipiracil (FTD/TPI) plus ramucirumab (RAM) versus trifluridine/tipiracil for previously treated patients with advanced gastric or esophagogastric junction adenocarcinoma (RETRIEVE study, WJOG15822G).
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-11199-1
- By:
- Publication type:
- Article
Panitumumab-Associated Drug-Induced Immune Thrombocytopenia in a Patient with Colorectal Cancer.
- Published in:
- Case Reports in Oncology, 2021, v. 14, n. 1, p. 85, doi. 10.1159/000512821
- By:
- Publication type:
- Article
Esophageal Metastasis from Rectal Cancer Successfully Treated with Fluorouracil-Based Chemotherapy with Bevacizumab: A Case Report and Review of the Literature.
- Published in:
- 2017
- By:
- Publication type:
- Case Study
Influence of precedent drug on the subsequent therapy in the sequence of trifluridine/tipiracil with/out bevacizumab and regorafenib for unresectable or recurrent colorectal cancer.
- Published in:
- PLoS ONE, 2022, v. 17, n. 6, p. 1, doi. 10.1371/journal.pone.0269115
- By:
- Publication type:
- Article
Tumor growth rate during re-challenge chemotherapy with previously used agents as salvage treatment for metastatic colorectal cancer: A retrospective study.
- Published in:
- PLoS ONE, 2021, v. 16, n. 9, p. 1, doi. 10.1371/journal.pone.0257551
- By:
- Publication type:
- Article
Expression of Integrin α3 in Gastric and Colorectal Cancers: Its Relation to Wall Contraction and Mode of Invasion.
- Published in:
- Cancer Science, 1995, v. 86, n. 10, p. 934, doi. 10.1111/j.1349-7006.1995.tb03004.x
- By:
- Publication type:
- Article
EGFR and HER2 signals play a salvage role in MEK1-mutated gastric cancer after MEK inhibition.
- Published in:
- International Journal of Oncology, 2015, v. 47, n. 2, p. 499, doi. 10.3892/ijo.2015.3050
- By:
- Publication type:
- Article
CRP and soluble CTLA4 are determinants of anti-PD1 resistance in gastrointestinal cancer.
- Published in:
- American Journal of Cancer Research, 2024, v. 14, n. 3, p. 1174, doi. 10.62347/NQBL9998
- By:
- Publication type:
- Article
ASO Author Reflections: What Is the Best Treatment for Gastric Cancer with Positive Peritoneal Lavage Cytology or Localized Peritoneum Metastasis?
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2020, v. 27, n. 3, p. 737, doi. 10.1245/s10434-019-08054-8
- By:
- Publication type:
- Article
Efficacy of Postoperative Chemotherapy After Resection that Leaves No Macroscopically Visible Disease of Gastric Cancer with Positive Peritoneal Lavage Cytology (CY1) or Localized Peritoneum Metastasis (P1a): A Multicenter Retrospective Study.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2020, v. 27, n. 1, p. 284, doi. 10.1245/s10434-019-07697-x
- By:
- Publication type:
- Article
Prognostic Value of Primary Tumor Sidedness for Unresectable Stage IV Colorectal Cancer: A Retrospective Study.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2019, v. 26, n. 5, p. 1358, doi. 10.1245/s10434-019-07209-x
- By:
- Publication type:
- Article
Treatment Pattern for Advanced Gastric Cancer in Japan and Factors Associated with Sequential Treatment: A Retrospective Administrative Claims Database Study.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 1, p. 296, doi. 10.1007/s12325-021-01931-3
- By:
- Publication type:
- Article
Shorter survival in adolescent and young adult patients, compared to adult patients, with stage IV colorectal cancer in Japan.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Early endpoints of a randomized phase II trial of preoperative chemotherapy with S-1/CDDP with or without trastuzumab followed by surgery for HER2-positive resectable gastric or esophagogastric junction adenocarcinoma with extensive lymph node metastasis: Japan Clinical Oncology Group study JCOG1301C (Trigger Study)
- Published in:
- Gastric Cancer, 2024, v. 27, n. 3, p. 580, doi. 10.1007/s10120-024-01467-9
- By:
- Publication type:
- Article
Rivoceranib, a VEGFR-2 inhibitor, monotherapy in previously treated patients with advanced or metastatic gastric or gastroesophageal junction cancer (ANGEL study): an international, randomized, placebo-controlled, phase 3 trial.
- Published in:
- Gastric Cancer, 2024, v. 27, n. 2, p. 375, doi. 10.1007/s10120-023-01455-5
- By:
- Publication type:
- Article
Short-term outcomes of preoperative chemotherapy with docetaxel, oxaliplatin, and S-1 for gastric cancer with extensive lymph node metastasis (JCOG1704).
- Published in:
- Gastric Cancer, 2024, v. 27, n. 2, p. 366, doi. 10.1007/s10120-023-01453-7
- By:
- Publication type:
- Article
5-year follow-up results of a JCOG1104 (OPAS-1) phase III non-inferiority trial to compare 4 courses and 8 courses of S-1 adjuvant chemotherapy for pathological stage II gastric cancer.
- Published in:
- Gastric Cancer, 2024, v. 27, n. 1, p. 155, doi. 10.1007/s10120-023-01447-5
- By:
- Publication type:
- Article
Perioperative TAS-118 plus oxaliplatin in patients with locally advanced gastric cancer: APOLLO-11 study.
- Published in:
- Gastric Cancer, 2023, v. 26, n. 4, p. 614, doi. 10.1007/s10120-023-01388-z
- By:
- Publication type:
- Article
Evaluating the efficacy of post-operative chemotherapy after curative resection of stage IV gastric cancer with synchronous oligo metastasis: a multicenter retrospective study.
- Published in:
- Gastric Cancer, 2023, v. 26, n. 2, p. 307, doi. 10.1007/s10120-023-01363-8
- By:
- Publication type:
- Article
Usefulness of an S-1 dosage formula: an exploratory analysis of randomized clinical trial (JCOG1001).
- Published in:
- Gastric Cancer, 2022, v. 25, n. 6, p. 1073, doi. 10.1007/s10120-022-01315-8
- By:
- Publication type:
- Article
Evaluation of clinical validity of an S-1 dosage formula based on renal function using data of the SPIRITS and the G-SOX trials.
- Published in:
- Gastric Cancer, 2022, v. 25, n. 4, p. 770, doi. 10.1007/s10120-022-01291-z
- By:
- Publication type:
- Article
Correction to: Real-world safety and effectiveness of nivolumab in Japanese patients with unresectable advanced or recurrent gastric/gastroesophageal junction cancer that has progressed after chemotherapy: a postmarketing surveillance study.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Real-world safety and effectiveness of nivolumab in Japanese patients with unresectable advanced or recurrent gastric/gastroesophageal junction cancer that has progressed after chemotherapy: a postmarketing surveillance study.
- Published in:
- Gastric Cancer, 2022, v. 25, n. 1, p. 245, doi. 10.1007/s10120-021-01244-y
- By:
- Publication type:
- Article
Nivolumab in previously treated advanced gastric cancer (ATTRACTION-2): 3-year update and outcome of treatment beyond progression with nivolumab.
- Published in:
- Gastric Cancer, 2021, v. 24, n. 4, p. 946, doi. 10.1007/s10120-021-01173-w
- By:
- Publication type:
- Article
Trastuzumab deruxtecan for the treatment of HER2-positive advanced gastric cancer: a clinical perspective.
- Published in:
- Gastric Cancer, 2021, v. 24, n. 3, p. 567, doi. 10.1007/s10120-021-01164-x
- By:
- Publication type:
- Article
Gastrectomy with or without neoadjuvant S-1 plus cisplatin for type 4 or large type 3 gastric cancer (JCOG0501): an open-label, phase 3, randomized controlled trial.
- Published in:
- Gastric Cancer, 2021, v. 24, n. 2, p. 492, doi. 10.1007/s10120-020-01136-7
- By:
- Publication type:
- Article
A nonrandomized, single-arm confirmatory trial of expanded endoscopic submucosal dissection indication for undifferentiated early gastric cancer: Japan Clinical Oncology Group study (JCOG1009/1010).
- Published in:
- Gastric Cancer, 2021, v. 24, n. 2, p. 479, doi. 10.1007/s10120-020-01134-9
- By:
- Publication type:
- Article
Posttherapy topographical nodal status, ypN-site, predicts survival of patients who received neoadjuvant chemotherapy followed by curative surgical resection for non-type 4 locally advanced gastric cancer: supplementary analysis of JCOG1004-A.
- Published in:
- Gastric Cancer, 2021, v. 24, n. 1, p. 197, doi. 10.1007/s10120-020-01098-w
- By:
- Publication type:
- Article
Randomized phase II/III study of 5-fluorouracil/l-leucovorin versus 5-fluorouracil/l-leucovorin plus paclitaxel administered to patients with severe peritoneal metastases of gastric cancer (JCOG1108/WJOG7312G).
- Published in:
- Gastric Cancer, 2020, v. 23, n. 4, p. 677, doi. 10.1007/s10120-020-01043-x
- By:
- Publication type:
- Article
Factors associated with technical difficulty of endoscopic submucosal dissection for early gastric cancer that met the expanded indication criteria: post hoc analysis of a multi-institutional prospective confirmatory trial (JCOG0607).
- Published in:
- Gastric Cancer, 2020, v. 23, n. 1, p. 168, doi. 10.1007/s10120-019-00991-3
- By:
- Publication type:
- Article